166 related articles for article (PubMed ID: 16633328)
1. Peptide hormones and lung cancer.
Moody TW
Panminerva Med; 2006 Mar; 48(1):19-26. PubMed ID: 16633328
[TBL] [Abstract][Full Text] [Related]
2. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
3. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the 5'-flanking region of the human gastrin-releasing peptide gene in small cell lung carcinoma cell lines.
Nagalla SR; Spindel ER
Cancer Res; 1994 Aug; 54(16):4461-7. PubMed ID: 8044796
[TBL] [Abstract][Full Text] [Related]
5. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
6. [The role of gastrin releasing peptide as a lung growth factor].
Thomas F; Morin A; Moreau JP; Calvo F; Poupon MF
Rev Mal Respir; 1992; 9(2):125-37. PubMed ID: 1565825
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma.
Maruno K; Yamaguchi K; Abe K; Suzuki M; Saijo N; Mishima Y; Yanaihara N; Shimosato Y
Cancer Res; 1989 Feb; 49(3):629-32. PubMed ID: 2535962
[TBL] [Abstract][Full Text] [Related]
8. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
9. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
[TBL] [Abstract][Full Text] [Related]
10. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
Carney DN; Cuttitta F; Moody TW; Minna JD
Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
[TBL] [Abstract][Full Text] [Related]
11. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
[TBL] [Abstract][Full Text] [Related]
12. [Recent advances in pathology and biology of small cell lung cancer].
Shimosato Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2513-21. PubMed ID: 2549878
[TBL] [Abstract][Full Text] [Related]
13. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer.
Oremek GM; Sapoutzis N
Anticancer Res; 2003; 23(2A):895-8. PubMed ID: 12820319
[TBL] [Abstract][Full Text] [Related]
14. Alpha-amidation of peptide hormones in lung cancer.
Quinn KA; Treston AM; Scott FM; Kasprzyk PG; Avis I; Siegfried JM; Mulshine JL; Cuttitta F
Cancer Cells; 1991 Dec; 3(12):504-10. PubMed ID: 1668141
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
vanderSpek JC; Sutherland JA; Zeng H; Battey JF; Jensen RT; Murphy JR
Cancer Res; 1997 Jan; 57(2):290-4. PubMed ID: 9000570
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene.
Markowitz S; Krystal G; Lebacq-Verheyden AM; Way J; Sausville EA; Battey J
J Clin Invest; 1988 Sep; 82(3):808-15. PubMed ID: 2843572
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
Okusaka T; Eguchi K; Kasai T; Kurata T; Yamamoto N; Ohe Y; Tamura T; Shinkai T; Saijo N
Clin Cancer Res; 1997 Jan; 3(1):123-7. PubMed ID: 9815547
[TBL] [Abstract][Full Text] [Related]
18. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?
Fischer B; Marinov M; Arcaro A
Cancer Treat Rev; 2007 Jun; 33(4):391-406. PubMed ID: 17368733
[TBL] [Abstract][Full Text] [Related]
19. Levels of high energy phosphates in human lung cancer cell lines by 31P nuclear magnetic resonance spectroscopy.
Knop RH; Carney DN; Chen CW; Cohen JS; Minna JD
Cancer Res; 1987 Jul; 47(13):3357-9. PubMed ID: 3034411
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer in never smokers: a review.
Subramanian J; Govindan R
J Clin Oncol; 2007 Feb; 25(5):561-70. PubMed ID: 17290066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
